Serum bilirubin and 10-year mortality risk in a Belgian population

Elisabeth H M Temme, Jianjun Zhang , Evert G. Schouten, Hugo Kesteloot

Research output: Contribution to journalArticle

146 Citations (Scopus)

Abstract

Objective: The endogenous antioxidant serum bilirubin may scavenge free radicals and protect against free radical-related diseases. Methods: Using the 10-year follow-up mortality data from the Belgium Inter-university Research on Nutrition and Health (BIRNH) study the association between serum bilirubin and all-cause, cardiovascular, and cancer mortality in 5460 men and 4843 women was investigated. Results: In men, with the highest (≥0.6 mg/dl) compared with the lowest serum bilirubin concentration (≤0.2 mg/dl), the adjusted relative risk (RR) was 0.73 (95% confidence interval (CI) 0.57-0.94) for all-cause and 0.42 (95% CI 0.26-0.68) for cancer mortality. The risk for cancer mortality decreased with increasing concentrations of serum bilirubin (p for trend=0.004) especially for non-lung cancer mortality (p for trend = 0.02). The associations persisted after adjusting for smoking. In women the associations between serum bilirubin and cancer mortality were in the same direction, but did not reach statistical significance (RR = 0.76, 95% CI 0.39-1.5). No significant associations were found between serum bilirubin and cardiovascular mortality in men and women. Conclusions: In this population high serum bilirubin, however, within normal ranges, was associated with low cancer mortality, especially in men. This may be due to the antioxidant activity of bilirubin. Measurement of serum bilirubin concentrations may contribute to cancer risk estimation.

Original languageEnglish (US)
Pages (from-to)887-894
Number of pages8
JournalCancer Causes and Control
Volume12
Issue number10
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Bilirubin
Mortality
Serum
Population
Neoplasms
Confidence Intervals
Free Radicals
Antioxidants
Belgium
Reference Values
Smoking
Health
Research

Keywords

  • Bilirubin
  • Cancer
  • Cardiovascular
  • Healthy subjects
  • Mortality
  • Prospective study

ASJC Scopus subject areas

  • Oncology
  • Epidemiology
  • Cancer Research

Cite this

Serum bilirubin and 10-year mortality risk in a Belgian population. / Temme, Elisabeth H M; Zhang , Jianjun; Schouten, Evert G.; Kesteloot, Hugo.

In: Cancer Causes and Control, Vol. 12, No. 10, 2001, p. 887-894.

Research output: Contribution to journalArticle

Temme, Elisabeth H M ; Zhang , Jianjun ; Schouten, Evert G. ; Kesteloot, Hugo. / Serum bilirubin and 10-year mortality risk in a Belgian population. In: Cancer Causes and Control. 2001 ; Vol. 12, No. 10. pp. 887-894.
@article{ddf1b2fc844045c2be4d8b0528fd6a8c,
title = "Serum bilirubin and 10-year mortality risk in a Belgian population",
abstract = "Objective: The endogenous antioxidant serum bilirubin may scavenge free radicals and protect against free radical-related diseases. Methods: Using the 10-year follow-up mortality data from the Belgium Inter-university Research on Nutrition and Health (BIRNH) study the association between serum bilirubin and all-cause, cardiovascular, and cancer mortality in 5460 men and 4843 women was investigated. Results: In men, with the highest (≥0.6 mg/dl) compared with the lowest serum bilirubin concentration (≤0.2 mg/dl), the adjusted relative risk (RR) was 0.73 (95{\%} confidence interval (CI) 0.57-0.94) for all-cause and 0.42 (95{\%} CI 0.26-0.68) for cancer mortality. The risk for cancer mortality decreased with increasing concentrations of serum bilirubin (p for trend=0.004) especially for non-lung cancer mortality (p for trend = 0.02). The associations persisted after adjusting for smoking. In women the associations between serum bilirubin and cancer mortality were in the same direction, but did not reach statistical significance (RR = 0.76, 95{\%} CI 0.39-1.5). No significant associations were found between serum bilirubin and cardiovascular mortality in men and women. Conclusions: In this population high serum bilirubin, however, within normal ranges, was associated with low cancer mortality, especially in men. This may be due to the antioxidant activity of bilirubin. Measurement of serum bilirubin concentrations may contribute to cancer risk estimation.",
keywords = "Bilirubin, Cancer, Cardiovascular, Healthy subjects, Mortality, Prospective study",
author = "Temme, {Elisabeth H M} and Jianjun Zhang  and Schouten, {Evert G.} and Hugo Kesteloot",
year = "2001",
doi = "10.1023/A:1013794407325",
language = "English (US)",
volume = "12",
pages = "887--894",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "10",

}

TY - JOUR

T1 - Serum bilirubin and 10-year mortality risk in a Belgian population

AU - Temme, Elisabeth H M

AU - Zhang , Jianjun

AU - Schouten, Evert G.

AU - Kesteloot, Hugo

PY - 2001

Y1 - 2001

N2 - Objective: The endogenous antioxidant serum bilirubin may scavenge free radicals and protect against free radical-related diseases. Methods: Using the 10-year follow-up mortality data from the Belgium Inter-university Research on Nutrition and Health (BIRNH) study the association between serum bilirubin and all-cause, cardiovascular, and cancer mortality in 5460 men and 4843 women was investigated. Results: In men, with the highest (≥0.6 mg/dl) compared with the lowest serum bilirubin concentration (≤0.2 mg/dl), the adjusted relative risk (RR) was 0.73 (95% confidence interval (CI) 0.57-0.94) for all-cause and 0.42 (95% CI 0.26-0.68) for cancer mortality. The risk for cancer mortality decreased with increasing concentrations of serum bilirubin (p for trend=0.004) especially for non-lung cancer mortality (p for trend = 0.02). The associations persisted after adjusting for smoking. In women the associations between serum bilirubin and cancer mortality were in the same direction, but did not reach statistical significance (RR = 0.76, 95% CI 0.39-1.5). No significant associations were found between serum bilirubin and cardiovascular mortality in men and women. Conclusions: In this population high serum bilirubin, however, within normal ranges, was associated with low cancer mortality, especially in men. This may be due to the antioxidant activity of bilirubin. Measurement of serum bilirubin concentrations may contribute to cancer risk estimation.

AB - Objective: The endogenous antioxidant serum bilirubin may scavenge free radicals and protect against free radical-related diseases. Methods: Using the 10-year follow-up mortality data from the Belgium Inter-university Research on Nutrition and Health (BIRNH) study the association between serum bilirubin and all-cause, cardiovascular, and cancer mortality in 5460 men and 4843 women was investigated. Results: In men, with the highest (≥0.6 mg/dl) compared with the lowest serum bilirubin concentration (≤0.2 mg/dl), the adjusted relative risk (RR) was 0.73 (95% confidence interval (CI) 0.57-0.94) for all-cause and 0.42 (95% CI 0.26-0.68) for cancer mortality. The risk for cancer mortality decreased with increasing concentrations of serum bilirubin (p for trend=0.004) especially for non-lung cancer mortality (p for trend = 0.02). The associations persisted after adjusting for smoking. In women the associations between serum bilirubin and cancer mortality were in the same direction, but did not reach statistical significance (RR = 0.76, 95% CI 0.39-1.5). No significant associations were found between serum bilirubin and cardiovascular mortality in men and women. Conclusions: In this population high serum bilirubin, however, within normal ranges, was associated with low cancer mortality, especially in men. This may be due to the antioxidant activity of bilirubin. Measurement of serum bilirubin concentrations may contribute to cancer risk estimation.

KW - Bilirubin

KW - Cancer

KW - Cardiovascular

KW - Healthy subjects

KW - Mortality

KW - Prospective study

UR - http://www.scopus.com/inward/record.url?scp=0035678766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035678766&partnerID=8YFLogxK

U2 - 10.1023/A:1013794407325

DO - 10.1023/A:1013794407325

M3 - Article

VL - 12

SP - 887

EP - 894

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 10

ER -